Kennedy Capital Management LLC Buys 23,060 Shares of Mesa Laboratories, Inc. $MLAB

Kennedy Capital Management LLC raised its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 19.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 144,606 shares of the medical instruments supplier’s stock after acquiring an additional 23,060 shares during the quarter. Kennedy Capital Management LLC’s holdings in Mesa Laboratories were worth $11,352,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Mesa Laboratories by 5,366.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 328 shares of the medical instruments supplier’s stock worth $26,000 after acquiring an additional 322 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in shares of Mesa Laboratories in the fourth quarter worth about $27,000. Kestra Advisory Services LLC bought a new position in shares of Mesa Laboratories in the fourth quarter worth about $55,000. BNP Paribas Financial Markets lifted its holdings in shares of Mesa Laboratories by 115.3% in the second quarter. BNP Paribas Financial Markets now owns 786 shares of the medical instruments supplier’s stock worth $74,000 after acquiring an additional 421 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Mesa Laboratories by 432.9% in the second quarter. Tower Research Capital LLC TRC now owns 842 shares of the medical instruments supplier’s stock worth $79,000 after acquiring an additional 684 shares during the last quarter. Institutional investors own 90.60% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings lowered shares of Mesa Laboratories from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and an average price target of $94.00.

Mesa Laboratories Price Performance

Shares of NASDAQ MLAB opened at $105.48 on Monday. The company has a 50 day simple moving average of $101.45 and a 200 day simple moving average of $90.24. The firm has a market cap of $582.25 million, a PE ratio of 87.90 and a beta of 0.94. Mesa Laboratories, Inc. has a 1 year low of $55.45 and a 1 year high of $113.99. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.72 and a quick ratio of 1.29.

Mesa Laboratories (NASDAQ:MLAB) last issued its quarterly earnings data on Wednesday, May 27th. The medical instruments supplier reported $1.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.78 by ($0.25). The business had revenue of $63.72 million during the quarter, compared to the consensus estimate of $65.21 million. Mesa Laboratories had a net margin of 2.69% and a return on equity of 20.96%. During the same quarter last year, the business earned ($1.31) EPS.

Mesa Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Friday, May 29th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, May 29th. Mesa Laboratories’s dividend payout ratio (DPR) is 53.33%.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.